http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1217925-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ee0bacab5a7576a6a3244747f6ea99 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64 |
filingDate | 1968-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef6074fcb453a53d69d115ebaf98cb5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae8eaaa161576b81312dffd33d4677fc |
publicationDate | 1971-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | GB-1217925-A |
titleOfInvention | Process for manufacture of phenyl-heterocyclic-acetic acid derivatives |
abstract | 1,217,925. Esters of alpha-(phenylheterocyclyl)alkanoic acids. IMPERIAL CHEMICAL INDUSTRIES Ltd. 6 May, 1969 [14 June, 1968], No. 28361/68. Heading C2C. Compounds of formula are prepared by reacting compounds of formula YXW(Het)CHR<SP>1</SP>R<SP>2</SP> with (R<SP>3</SP>) 2 CO 3 and M, MH, MNH 2 or C 1-3 - alkyl - OM, wherein "Het" is an oxazole or thiazole nucleus with the CR<SP>1</SP>R<SP>2</SP> side-chain in position 2, or a pyrimidine or pyridine nucleus with the CR<SP>1</SP>R<SP>2</SP> side-chain in position 2, 4 or 6; R<SP>2</SP> and W, H or Me, X is H or MeO, Y is Ph (possibly CF 3 or mono- or di-halogen i.e. F, Cl or Br, substituted), R<SP>1</SP> is Me or Et, R<SP>3</SP> is C 1-4 alkyl and M is Na or K, Y and the CR<SP>1</SP>R<SP>2</SP> side-chain being in non-adjacent positions in "Het". Pharmaceutically acceptable acid addition salts may be formed subsequently. Reference has been directed by the Comptroller to Specifications 1,099,389,1,121,922, 1,139,940 and 1,147,068. |
priorityDate | 1968-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.